8-K: NRC Health Announces Fourth Quarter Results: Revenue and Earnings Decline

NRC Health reports a decrease in revenue and earnings per share for the fourth quarter of 2024 compared to the same period in 2023, alongside the resignation of its Chief Product Technology Officer.

Summary

• National Research Corporation, dba NRC Health, announced its financial results for the fourth quarter of 2024.
• Revenue for the quarter was approximately $36.9 million, down from $38.0 million in the same quarter of 2023.
• Earnings per diluted share decreased to $0.28, compared to $0.36 in the fourth quarter of 2023.
• The company's net indebtedness was approximately $58.5 million as of December 31, 2024.
• Total recurring contract value (TRCV) stood at approximately $133.2 million at the end of 2024.
• NRC Health returned approximately $10.1 million to stockholders through dividends and stock repurchases during the quarter.
• The company repurchased approximately 393,000 shares for about $7.3 million and paid a quarterly dividend of $0.12 per share, totaling approximately $2.8 million.
• Chrisophe Louvion, the Company's Chief Product Technology Officer, has resigned.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to decreased revenue and earnings, offset somewhat by stock repurchases and dividend payments. The resignation of the Chief Product Technology Officer adds to the negative sentiment.

Positives

• The company returned $10.1 million to stockholders through dividends and stock repurchases.
• Total recurring contract value (TRCV) was $133.2 million at the end of 2024.

Negatives

• Fourth-quarter revenue decreased to $36.9 million from $38.0 million in the prior year.
• Earnings per diluted share declined to $0.28 from $0.36 year-over-year.
• Net indebtedness reached $58.5 million as of December 31, 2024.
• Chrisophe Louvion, the Company's Chief Product Technology Officer, has resigned.

Risks

• The press release contains forward-looking statements subject to risks and uncertainties as detailed in the company's filings with the SEC.
• Decreased revenue and earnings could indicate challenges in the company's market position or service offerings.
• Increased net indebtedness could pose financial risks if not managed effectively.

Future Outlook

The press release contains forward-looking statements regarding future dividends, which are subject to risks and uncertainties.

Industry Context

The healthcare industry is constantly evolving, and companies like NRC Health must adapt to changing consumer preferences and market dynamics to maintain their competitive edge.

Comparison to Industry Standards

• It is difficult to compare NRC Health's results without knowing the specific performance of its direct competitors in the patient experience and healthcare intelligence market.
• Companies like Press Ganey and Vocera Communications (now part of Stryker) are key players in similar spaces, and their financial performance would provide a useful benchmark.
• Comparing TRCV and net indebtedness to these competitors would offer insights into NRC Health's relative financial health and growth potential.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the decrease in revenue and earnings per share.
• Employees may experience uncertainty due to the management change.
• Customers may be affected if the company's service offerings or quality are impacted by the financial performance.

Key Dates